We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Multi-Spectral Device Images Blood Flow and Perfusion

By HospiMedica International staff writers
Posted on 24 Jan 2019
A new device reveals real-time blood flow and perfusion in vascular structures and critical tissues during surgery.

The RFPi (Greenville, NC, USA) iCertainty platform provides non-invasive, real-time multi-spectral physiologic visualization (MSPV), a combination of low-energy lasers, high-speed imaging cameras, patented analysis techniques, and flow-calculation algorithms that together can deliver real-time visualization and quantification of blood flow and perfusion. More...
The system does not require contrast agent injections, dyes, or radiation, in contrast to traditional modalities such as X-ray, ultrasound, and magnetic resonance imaging (MRI).

The system can image blood flow and perfusion in skin and tissue to a depth of 4-5mm, with potential applications including gastrointestinal and plastic surgery, as well as lower-leg vascular procedures. By allowing surgeons to immediately visualize blood flow and perfusion, iCertainty offers the potential to reduce procedural complications or repeat surgeries, reduce hospital costs, and objectively measure and improve clinical outcomes. The company is also developing a mobile device for outpatient settings, such as wound care and diabetic clinics.

“Repeat surgery rates in iCertainty’s target indications run as high as twenty percent, a figure that masks a tremendous amount of patient discomfort, uncertainty and inconvenience, as well as financial loss for hospitals and insurers,” said Jeffery Basham, CEO of RFPi. “iCertainty offers an entirely new and advanced standard of imaging detail, speed, ease and flexibility that should benefit surgeons, hospitals and third-party payers and, most importantly, the patients they all care for.”

Related Links:
RFPi


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Medical Adhesive
MED 5570U
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.